2-(3-(tert-Butylamino)-2-methylquinoxalin-5-yl)-4H-thieno[2,3-c]pyrrol-6(5H)-one

ID: ALA4527131

Chembl Id: CHEMBL4527131

PubChem CID: 155544306

Max Phase: Preclinical

Molecular Formula: C19H20N4OS

Molecular Weight: 352.46

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1nc2cccc(-c3cc4c(s3)C(=O)NC4)c2nc1NC(C)(C)C

Standard InChI:  InChI=1S/C19H20N4OS/c1-10-17(23-19(2,3)4)22-15-12(6-5-7-13(15)21-10)14-8-11-9-20-18(24)16(11)25-14/h5-8H,9H2,1-4H3,(H,20,24)(H,22,23)

Standard InChI Key:  JILYBMJSGXWKEA-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4527131

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 352.46

Molecular Weight (Monoisotopic): 352.1358

AlogP: 4.12

#Rotatable Bonds: 2

Polar Surface Area: 66.91

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.13

CX Basic pKa: 2.23

CX LogP: 2.93

CX LogD: 2.93

Aromatic Rings: 3

Heavy Atoms: 25

QED Weighted: 0.73

Np Likeness Score: -0.66

References

1. Pettus LH, Andrews KL, Booker SK, Chen J, Cee VJ, Chavez F, Chen Y, Eastwood H, Guerrero N, Herberich B, Hickman D, Lanman BA, Laszlo J, Lee MR, Lipford JR, Mattson B, Mohr C, Nguyen Y, Norman MH, Powers D, Reed AB, Rex K, Sastri C, Tamayo N, Wang P, Winston JT, Wu B, Wu T, Wurz RP, Xu Y, Zhou Y, Tasker AS, Wang HL..  (2016)  Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.,  59  (13): [PMID:27285051] [10.1021/acs.jmedchem.6b00610]

Source

Source(1):

• Scientific Literature